Fecal microbiota transplantation: therapeutical approaches and regulatory framework

Since Ilya Metchnikoff’s studies, both medical science and clinical practice have accumulated a large amount of evidence that human intestinal microbiota possesses a unique characteristics for our existence. However, only recently, scientists have achieved the actual breakthrough in this field of hu...

Full description

Saved in:
Bibliographic Details
Main Authors: A. N. Vasilyev, D. V. Goryachev, E. V. Gavrishina, R. R. Niyazov, Yu. A. Seliverstov, A. V. Digtyar
Format: Article
Language:Russian
Published: Ministry of Health of the Russian Federation. Federal State Budgetary Institution «Scientific Centre for Expert Evaluation of Medicinal Products» 2018-02-01
Series:Биопрепараты: Профилактика, диагностика, лечение
Subjects:
Online Access:https://www.biopreparations.ru/jour/article/view/10
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849342734982184960
author A. N. Vasilyev
D. V. Goryachev
E. V. Gavrishina
R. R. Niyazov
Yu. A. Seliverstov
A. V. Digtyar
author_facet A. N. Vasilyev
D. V. Goryachev
E. V. Gavrishina
R. R. Niyazov
Yu. A. Seliverstov
A. V. Digtyar
author_sort A. N. Vasilyev
collection DOAJ
description Since Ilya Metchnikoff’s studies, both medical science and clinical practice have accumulated a large amount of evidence that human intestinal microbiota possesses a unique characteristics for our existence. However, only recently, scientists have achieved the actual breakthrough in this field of human physiology, and we start to understand the precise mechanisms of the complex interplay of microbial activity with human homeostasis and discover numerous new functions of intestinal microbes. In this regard, a novel medical technology evolves since 1958, so called fecal microbiota transplantation (FMT), which is the administration of donor feces to the patients suffering from different kinds of diseases. Such infusion of donor feces restores the natural balance of gut commensal germs. FMT is most efficacious in severe or recurrent Clostridium difficile infection. FMT has been also reported to cure diarrhea and constipation caused by different conditions, such as multiple sclerosis, Crohn ’s disease etc. In the U.S. and Canada as well as in other countries FMT is of uttermost interest of not merely clinical practitioners but lately also of regulatory authorities. The paper also addresses the possibility of application the Russian pharmaceutical legislation to FMT.
format Article
id doaj-art-5aa7e4fa05f04e6a82851d73733c556d
institution Kabale University
issn 2221-996X
2619-1156
language Russian
publishDate 2018-02-01
publisher Ministry of Health of the Russian Federation. Federal State Budgetary Institution «Scientific Centre for Expert Evaluation of Medicinal Products»
record_format Article
series Биопрепараты: Профилактика, диагностика, лечение
spelling doaj-art-5aa7e4fa05f04e6a82851d73733c556d2025-08-20T03:43:15ZrusMinistry of Health of the Russian Federation. Federal State Budgetary Institution «Scientific Centre for Expert Evaluation of Medicinal Products»Биопрепараты: Профилактика, диагностика, лечение2221-996X2619-11562018-02-0102152310Fecal microbiota transplantation: therapeutical approaches and regulatory frameworkA. N. Vasilyev0D. V. Goryachev1E. V. Gavrishina2R. R. Niyazov3Yu. A. Seliverstov4A. V. Digtyar5Federal State Budgetary Institution «Scientific Center on Expertise of Medical Application Products» of the Ministry of Health of the Russian FederationFederal State Budgetary Institution «Scientific Center on Expertise of Medical Application Products» of the Ministry of Health of the Russian FederationFederal State Budgetary Institution «Scientific Center on Expertise of Medical Application Products» of the Ministry of Health of the Russian FederationFederal State Budgetary Institution «Scientific Center on Expertise of Medical Application Products» of the Ministry of Health of the Russian FederationFederal State Budgetary Scientific Institution «Research Center of Neurology», Russian Academy of SciencesFederal State Budgetary Institution «Scientific Center on Expertise of Medical Application Products» of the Ministry of Health of the Russian FederationSince Ilya Metchnikoff’s studies, both medical science and clinical practice have accumulated a large amount of evidence that human intestinal microbiota possesses a unique characteristics for our existence. However, only recently, scientists have achieved the actual breakthrough in this field of human physiology, and we start to understand the precise mechanisms of the complex interplay of microbial activity with human homeostasis and discover numerous new functions of intestinal microbes. In this regard, a novel medical technology evolves since 1958, so called fecal microbiota transplantation (FMT), which is the administration of donor feces to the patients suffering from different kinds of diseases. Such infusion of donor feces restores the natural balance of gut commensal germs. FMT is most efficacious in severe or recurrent Clostridium difficile infection. FMT has been also reported to cure diarrhea and constipation caused by different conditions, such as multiple sclerosis, Crohn ’s disease etc. In the U.S. and Canada as well as in other countries FMT is of uttermost interest of not merely clinical practitioners but lately also of regulatory authorities. The paper also addresses the possibility of application the Russian pharmaceutical legislation to FMT.https://www.biopreparations.ru/jour/article/view/10fecal microbiota transplantationfmtgut microbiotaclostridium difficilemultiple sclerosisprobioticantibioticpharmaceutical legislationкишечная микробиотатрансплантация кишечной микробиотыclostridium difficileрассеянный склерозпробиотикэубиотикантибиотикзаконодательство в сфере обращения лекарственных средств
spellingShingle A. N. Vasilyev
D. V. Goryachev
E. V. Gavrishina
R. R. Niyazov
Yu. A. Seliverstov
A. V. Digtyar
Fecal microbiota transplantation: therapeutical approaches and regulatory framework
Биопрепараты: Профилактика, диагностика, лечение
fecal microbiota transplantation
fmt
gut microbiota
clostridium difficile
multiple sclerosis
probiotic
antibiotic
pharmaceutical legislation
кишечная микробиота
трансплантация кишечной микробиоты
clostridium difficile
рассеянный склероз
пробиотик
эубиотик
антибиотик
законодательство в сфере обращения лекарственных средств
title Fecal microbiota transplantation: therapeutical approaches and regulatory framework
title_full Fecal microbiota transplantation: therapeutical approaches and regulatory framework
title_fullStr Fecal microbiota transplantation: therapeutical approaches and regulatory framework
title_full_unstemmed Fecal microbiota transplantation: therapeutical approaches and regulatory framework
title_short Fecal microbiota transplantation: therapeutical approaches and regulatory framework
title_sort fecal microbiota transplantation therapeutical approaches and regulatory framework
topic fecal microbiota transplantation
fmt
gut microbiota
clostridium difficile
multiple sclerosis
probiotic
antibiotic
pharmaceutical legislation
кишечная микробиота
трансплантация кишечной микробиоты
clostridium difficile
рассеянный склероз
пробиотик
эубиотик
антибиотик
законодательство в сфере обращения лекарственных средств
url https://www.biopreparations.ru/jour/article/view/10
work_keys_str_mv AT anvasilyev fecalmicrobiotatransplantationtherapeuticalapproachesandregulatoryframework
AT dvgoryachev fecalmicrobiotatransplantationtherapeuticalapproachesandregulatoryframework
AT evgavrishina fecalmicrobiotatransplantationtherapeuticalapproachesandregulatoryframework
AT rrniyazov fecalmicrobiotatransplantationtherapeuticalapproachesandregulatoryframework
AT yuaseliverstov fecalmicrobiotatransplantationtherapeuticalapproachesandregulatoryframework
AT avdigtyar fecalmicrobiotatransplantationtherapeuticalapproachesandregulatoryframework